Evidence map›Paper›PMID 40009272›Full record

ArticleVeterinary research communications2025

Duration of the antibody response following intradermal administration of a quarter-dose oil adjuvant foot-and-mouth disease vaccine in sheep.

Tunçer Türkoğlu, Ünal Parlak, Pelin Tuncer-Göktuna, Eylem Aras-Uzun, Sena İnel-Turgut, Erdoğan Asar, Ayça Kürkçü, Can Çokçalışkan

Abstract read
PubMed Publisher
In one paragraph

Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tunçer TürkoğluŞap (Foot and Mouth Disease) Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-6780-6186
Ünal ParlakŞap (Foot and Mouth Disease) Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Ankara, Türkiye.ORCID http://orcid.org/0000-0003-2870-8345
Pelin Tuncer-GöktunaPendik Veterinary Control Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-7468-0155
Eylem Aras-UzunŞap (Foot and Mouth Disease) Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Ankara, Türkiye.ORCID http://orcid.org/0000-0001-5845-4791
Sena İnel-TurgutŞap (Foot and Mouth Disease) Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-0907-1193
Erdoğan AsarGulhane Faculty of Medicine, Division of Basic Medical Sciences, Department of Medical Informatics, University of Health Sciences, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-6987-7068
Ayça KürkçüŞap (Foot and Mouth Disease) Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-6411-917X
Can ÇokçalışkanŞap (Foot and Mouth Disease) Institute, Republic of Türkiye, Ministry of Agriculture and Forestry, Ankara, Türkiye. can.cokcaliskan@tarimorman.gov.tr.ORCID http://orcid.org/0000-0002-3839-0986

Funding

Şap Institute 2021-01
6 · The paper itself

Abstract

Foot-and-mouth disease is a significant viral disease affecting cloven-hoofed domestic and wild animals. One of the most effective measures for combating this disease is vaccination. However, sheep are often excluded from vaccination campaigns because of vaccine shortages. Intradermal vaccination can significantly reduce the quantity of antigens and adjuvants required, thereby increasing vaccine availability. Although numerous experimental studies have been conducted on the intradermal administration of the FMD vaccine, no such studies have been conducted on sheep, and the duration of antibody response for this species remains unclear. Inactivated antigens for foot-and-mouth disease, including O/Panasia-II, A/IRN-05, A/ASIA/G-VII, and ASIA1/Sindh-08, were formulated using ictyolane 18 and ictyolane 30 adjuvants to prepare water-in-oil-in-water and microemulsions. Forty-five Merino sheep were randomly divided into four groups of 10 animals each, with one unvaccinated group containing five animals. One mL of vaccine (> 3PD

Indexed as

Antibodies, ViralAntibody FormationFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusSheep DiseasesViral VaccinesAdjuvants, ImmunologicAdjuvants, VaccineAnimalsInjections, IntradermalInjections, IntramuscularSheepVaccinationAdjuvants, ImmunologicAdjuvants, VaccineAntibodies, ViralViral VaccinesAdjuvantDuration of immunityFoot-and-mouth diseaseIctyolaneIntradermal vaccinationVaccine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.